These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1018 related items for PubMed ID: 17654743

  • 1. A lipidomic analysis of nonalcoholic fatty liver disease.
    Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ.
    Hepatology; 2007 Oct; 46(4):1081-90. PubMed ID: 17654743
    [Abstract] [Full Text] [Related]

  • 2. The plasma lipidomic signature of nonalcoholic steatohepatitis.
    Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ.
    Hepatology; 2009 Dec; 50(6):1827-38. PubMed ID: 19937697
    [Abstract] [Full Text] [Related]

  • 3. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
    Scorletti E, Byrne CD.
    Annu Rev Nutr; 2013 Dec; 33():231-48. PubMed ID: 23862644
    [Abstract] [Full Text] [Related]

  • 4. Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model.
    Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, Wright JK, Matrisian LM, Brown HA.
    PLoS One; 2011 Dec; 6(8):e22775. PubMed ID: 21857953
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN.
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
    Wang ZH, Zheng KI, Wang XD, Qiao J, Li YY, Zhang L, Zheng MH, Wu J.
    Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
    [Abstract] [Full Text] [Related]

  • 8. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J, Choi SS, Diehl AM.
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [Abstract] [Full Text] [Related]

  • 10. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S, Yukawa T, Uetake S, Yamauchi M.
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.
    Stanković MN, Mladenović DR, Duričić I, Šobajić SS, Timić J, Jorgačević B, Aleksić V, Vučević DB, Ješić-Vukićević R, Radosavljević TS.
    Arch Med Res; 2014 Feb; 45(2):116-24. PubMed ID: 24480733
    [Abstract] [Full Text] [Related]

  • 13. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M.
    Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
    [Abstract] [Full Text] [Related]

  • 14. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.
    Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY.
    Dig Dis Sci; 2005 Dec; 50(12):2338-43. PubMed ID: 16416185
    [Abstract] [Full Text] [Related]

  • 15. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
    Bechmann LP, Kocabayoglu P, Sowa JP, Sydor S, Best J, Schlattjan M, Beilfuss A, Schmitt J, Hannivoort RA, Kilicarslan A, Rust C, Berr F, Tschopp O, Gerken G, Friedman SL, Geier A, Canbay A.
    Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
    [Abstract] [Full Text] [Related]

  • 16. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT, de Oliveira CP, Corrêa-Giannella ML, Soares IC, Kubrusly MS, Bellodi-Privato M, de Mello ES, de Lima VM, Carrilho FJ, Alves VA.
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [Abstract] [Full Text] [Related]

  • 17. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA, Kunde SS, Lazenby AJ, Clements RH.
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [Abstract] [Full Text] [Related]

  • 18. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis.
    Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, Endo H, Takahashi H, Inamori M, Kobayashi N, Kirikoshi H, Kubota K, Saito S, Nakajima A.
    Hepatology; 2009 Sep; 50(3):772-80. PubMed ID: 19650159
    [Abstract] [Full Text] [Related]

  • 19. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP, Park SJ, Harrison SA.
    J Clin Gastroenterol; 2012 Apr 01; 46(5):427-30. PubMed ID: 22469639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.